Expressing support for the designation of the last Tuesday of April each year as "APOL1-Mediated Kidney Disease (AMKD) Awareness Day".

1. 01

   How might an official awareness day for APOL1-mediated kidney disease influence funding priorities or research attention for this specific condition?

2. 02

   What evidence shows that congressional awareness designations lead to measurable changes in public knowledge or patient outcomes for rare diseases?

3. 03

   Which communities or patient populations would benefit most from increased visibility of APOL1-mediated kidney disease, and why?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.